RCT: Tofacitinib reduced the risk of death or respiratory failure in patients hospitalized with Covid-19 pneumonia.
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia – New England Journal of Medicine News release: Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia Commentary on Twitter: Patients who were hospitalized with #COVID19 pneumonia were randomly assigned, at a median […]
The post RCT: Tofacitinib reduced the risk of death or respiratory failure in patients hospitalized with Covid-19 pneumonia. appeared first on Links Medicus.
RCT: A brief advice + nicotine replacement therapy sampling + active referral nearly doubled the odds of validated quitting among expectant fathers who smoked.
Brief Advice, Nicotine Replacement Therapy Sampling, and Active Referral for Expectant Fathers Who Smoke Cigarettes: A Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)
The post RCT: A brief advice + nicotine replacement therapy sampling + active referral nearly doubled the odds of validated quitting among expectant fathers who smoked. appeared first on Links Medicus.
M-A: Extracorporeal membrane oxygenation for COVID-19.
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis – Critical Care
The post M-A: Extracorporeal membrane oxygenation for COVID-19. appeared first on Links Medicus.
France recommends single dose of vaccine if previous Covid infection detected.
France recommends single dose of vaccine if previous Covid infection detected – Rfi Related: [Preprint] More data showing a single-dose SARS-CoV-2 mRNA vaccine may be enough in individuals with previous COVID-19. AND Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19
The post France recommends single dose of vaccine if previous Covid infection detected. appeared first on Links Medicus.
A long-term perspective on immunity to COVID – “Clinical studies now indicate that immunity will be long-lasting”.
A long-term perspective on immunity to COVID – Nature
The post A long-term perspective on immunity to COVID – “Clinical studies now indicate that immunity will be long-lasting”. appeared first on Links Medicus.
M-A: The incubation period distribution of coronavirus disease 2019 – “the mean incubation period of COVID-19 was likely to fall between 5.2 and 7.2 days, and the 95th percentile would be between 11 and 14.6 days”.
The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis – Clinical Infectious Diseases
The post M-A: The incubation period distribution of coronavirus disease 2019 – “the mean incubation period of COVID-19 was likely to fall between 5.2 and 7.2 days, and the 95th percentile would be between 11 and 14.6 days”. appeared first on Links Medicus.
Cardio-pulmonary sequelae in recovered COVID-19 patients: considerations for primary care.
Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care – Journal of Primary Care & Community Health
The post Cardio-pulmonary sequelae in recovered COVID-19 patients: considerations for primary care. appeared first on Links Medicus.
Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report.
Almost 25% of COVID-19 Patients Develop Long-Lasting Symptoms, According to a New Report – TIME Original report: A Detailed Study of Patients with Long-Haul COVID – FAIR Health Commentary on Twitter (thread – click for more) ?1 in 4–almost a quarter of people infected develop at least one lingering health problem after 30 days […]
The post Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report. appeared first on Links Medicus.
Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series – Annals of Internal Medicine Commentaries: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection – Hopkins Medicine AND Extra COVID Vaccine May Help Protect Transplant Patients – Associated Press Commentary […]
The post Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients. appeared first on Links Medicus.
Delta variant producing more severe illness, doctors in China say.
In China’s latest outbreak, doctors say the infected get sicker, faster. – The New York Times (a few articles per month are free)
The post Delta variant producing more severe illness, doctors in China say. appeared first on Links Medicus.